A recombinant live oral cholera vaccine

58Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

A pathogenic strain of Vibrio cholerae was attenuated by deletion of DNA sequences encoding the A1 subunit of the cholera enterotoxin. A restriction endonuclease fragment encoding the A1, but not the A2 or B sequences was deleted in vitro from cloned cholera toxin genes. The mutation was then recombined into the chromosome of V.cholerae Ogawa 395, a pathogenic strain that confers complete immunity to subsequent infection following an initial clinical infection. The resulting strain, which produces the immunogenic but nontoxic B subunit of cholera toxin and is unaltered in other critical antigens, represents a promising candidate for an attenuated live oral cholera vaccine. © 1984, Nature Publishing Group. All rights reserved.

Cite

CITATION STYLE

APA

Kaper, J. B., Lockman, H., Baldini, M. M., & Levine, M. M. (1984). A recombinant live oral cholera vaccine. Bio/Technology, 2(4), 345–349. https://doi.org/10.1038/nbt0484-345

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free